The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Beta Bionics Inc shares valued at $66,221 were sold by Mensinger Mike on Jan 06 ’26. At $30.10 per share, Mensinger Mike sold 2,200 shares. The insider’s holdings dropped to 80,752 shares worth approximately $1.44 million following the completion of this transaction.
Also, Mensinger Mike sold 7,800 shares, netting a total of over 230,950 in proceeds. Following the sale of shares at $29.61 each, the insider now holds 82,952 shares.
Before that, Feider Stephen had sold 20,000 shares from its account. In a trade valued at $590,680, the Chief Financial Officer traded Beta Bionics Inc shares for $29.53 each. Upon closing the transaction, the insider’s holdings decreased to 20,000 shares, worth approximately $0.76 million.
As published in a research note from BofA Securities on January 09, 2026, Beta Bionics Inc [BBNX] has been rated down from a Buy to a Neutral. As of October 01, 2025, Goldman has increased its “Neutral” rating to a “Buy” for BBNX. Earlier on June 16, 2025, Truist initiated its rating. Their recommendation was “a Buy” for BBNX stock.
Analyzing BBNX Stock Performance
On last trading session, Beta Bionics Inc [NASDAQ: BBNX] rose 4.71% to $17.79. The stock’s lowest price that day was $16.25, but it reached a high of $17.86 in the same session. During the last five days, there has been a drop of approximately -44.39%.
Support And Resistance Levels for Beta Bionics Inc (BBNX)
RSI (Relative Strength Index) is 26.24 on the 14-day chart, showing oversold technical sentiment.
Is Beta Bionics Inc subject to short interest?
Stocks of Beta Bionics Inc saw a sharp rise in short interest on 2025-12-31 jumping by 3.44 million shares to 7.3 million. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 3.86 million shares. A jump of 47.12% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.18 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.18.
Which companies own the most shares of Beta Bionics Inc (BBNX)?
In terms of Beta Bionics Inc share price expectations, FactSet research, analysts set an average price target of 31.5 in the next 12 months, up nearly 85.4% from the previous closing price of $16.99. Analysts anticipate Beta Bionics Inc stock to reach 40 by 2026, with the lowest price target being 25. On June 12, 2025, Lake Street assigned a price target of “a Buy” to the stock and initiated coverage with a $30.
